L. Wood

Thyroid function test abnormalities in patients with metastatic renal cell carcinoma treated with sorafenib

Ila Tamaskar, Ronald M. Bukowski, Paul Elson et al. · Annals of Oncology · 2007 · 147 citations

Urology, Genitourinary Cancer, Medicine +4

A 2weeks on and 1week off schedule of sunitinib is associated with decreased toxicity in metastatic renal cell carcinoma

Yana G. Najjar, Kriti Mittal, Paul Elson et al. · European Journal of Cancer · 2014 · 111 citations

Urology, Oncology, Genitourinary Cancer +4

Sunitinib and sorafenib in metastatic renal cell carcinoma patients with renal insufficiency

Gazala Khan, Ali Golshayan, Paul Elson et al. · Annals of Oncology · 2010 · 55 citations

Urology, Renal Insufficiency, Genitourinary Cancer +5

Temsirolimus in VEGF-refractory metastatic renal cell carcinoma

Mary J. MacKenzie, Brian I. Rini, Paul Elson et al. · Annals of Oncology · 2010 · 53 citations · Full text

Cancer Growth, Urology, Kidney Research +1

Thyroid function tests (TFTs) abnormalities in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with sunitinib

Philip Shaheen, Ila Tamaskar, R. N. Salas et al. · Journal of Clinical Oncology · 2006 · 26 citations

Tfts Assessment, Renal Pathology, Pharmacotherapy +18